ArticleInternational journal of clinical pharmacy2022

A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation.

Meixiang Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.